Public-registry site landscape for NCT02251067, a Diabetic Nephropathy study sponsored by Vascular Pharmaceuticals, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02251067 (registry record) |
| Sponsor | Vascular Pharmaceuticals, Inc. |
| Condition(s) | Diabetic Nephropathy |
| Phase | PHASE2 |
| Listed sites | 34 |
| Site countries | United States, Puerto Rico |
Eichor generates a preliminary site-risk snapshot for NCT02251067 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →